A UK-led international clinical trial is recruiting 280 patients to see if the technique to remove cancerous cells could ...
The new project could ‘help surgeons to visualise tumours during keyhole surgery’. The National Institute for Health Research (NIHR) has announced that a new ‘probe’ that detects prostate cancer could ...
A probe that shrinks enlarged prostates in just 30 minutes could cure a condition that affects 2.5million men in the UK. The device uses a mild electric current to treat benign prostatic hyperplasia, ...
Gen-Probe (NASDAQ: GPRO) announced today the US Food and Drug Administration (FDA) has approved its PROGENSA ® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine the need ...
Urology specialist Professor Vincent Gnanapragasam and his team at Cambridge University and Cambridge University Hospitals NHS Trust devised the Cambridge Prostate Biopsy Device (CamPROBE) to reduce ...
This study looked at a device called CamPROBE to take tissue samples (biopsies) to help diagnose prostate cancer. It was open for people to join during 2019, and the team published the results in 2020 ...
Gen-Probe Incorporated and DiagnoCure Inc. has announced that the companies have signed an amendment to their 2003 license agreement, establishing new FDA submission milestones and key distribution ...
This study looked at a device called CamPROBE to take tissue samples (biopsies) to help diagnose prostate cancer. It was open for people to join during 2019, and the team published the results in 2020 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback